Business Context and Reporting Period
This Form 8-K was filed by Sintx Technologies, Inc. (formerly Amedica Corporation) on October 30, 2018. The report details the formal consummation of a corporate name change effective October 30, 2018, following the sale of specific assets to CTL Medical Corporation on October 1, 2018.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Corporate Name Change: The company officially changed its name from "Amedica Corporation" to "Sintx Technologies, Inc." effective October 30, 2018.
- Asset Sale Completion: The name change follows the October 1, 2018, sale of assets and liabilities related to the "Amedica" business, including all rights to the name, to CTL Medical Corporation.
- Stock Identification: The CUSIP number for the company's common stock has been updated to 829392109.
- Legal Amendments: The company filed a Certificate of Amendment to its Restated Certificate of Incorporation and amended its bylaws to reflect the new name.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors beyond the context of the completed asset sale and name change. The document serves as a notification of the legal formalities required by the Asset Purchase Agreement.
Investor Verification Checklist
- Verify the new CUSIP number (829392109) for trading purposes.
- Confirm the legal status of the remaining business operations post-asset sale to CTL Medical Corporation.
- Review the attached Certificate of Amendment (Exhibit 3.1) and Bylaws Amendment (Exhibit 3.2) for any other structural changes.